Two Sigma Securities, LLC Acadia Pharmaceuticals Inc Call Options Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2020

May 15, 2020
SELL
$31.65 - $46.87 $620,340 - $918,652
-19,600 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$36.21 - $51.4 $709,716 - $1.01 Million
19,600 New
19,600 $838,000
Q2 2019

Aug 14, 2019
SELL
$23.32 - $28.12 $230,868 - $278,388
-9,900 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$16.17 - $27.38 $160,083 - $271,062
9,900 New
9,900 $266,000

Others Institutions Holding ACAD

# of Institutions
280
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.62B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email